Genus (LON:GNS – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at Berenberg Bank in a report issued on Thursday, Marketbeat Ratings reports. They currently have a GBX 3,350 price target on the stock. Berenberg Bank’s price objective indicates a potential upside of 6.50% from the company’s previous close.
Several other brokerages have also commented on GNS. Shore Capital restated a “buy” rating and set a GBX 3,000 price target on shares of Genus in a research note on Friday, January 16th. Deutsche Bank Aktiengesellschaft increased their target price on shares of Genus from GBX 3,100 to GBX 3,300 and gave the stock a “buy” rating in a report on Friday, January 16th. Three equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Genus presently has a consensus rating of “Buy” and an average price target of GBX 3,216.67.
Get Our Latest Analysis on GNS
Genus Trading Up 2.8%
About Genus
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.
Featured Stories
- Five stocks we like better than Genus
- The day the gold market broke
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- What a Former CIA Agent Knows About the Coming Collapse
- Your Bank Account Is No Longer Safe
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.
